Neil Floch MD

This account is verified. Learn more

@NeilFlochMD

Associate Professor #DABOM @Yalemed #Obesity #SoMe Editor @soard_journal / bariatric surgery Tweets are my views and not my employer @yalesurgery

Connecticut drneilfloch.com Joined October 2013

99K Following 130K Followers 104K Posts

Latest posts 5

Pinned post

Neil Floch MD @NeilFlochMD Oct 21

I am a doctor
I am a surgeon

Despite the many imperfections in medicine today and the vast problems in healthcare…..

I sincerely love my job.

I love surgery and I find no greater satisfaction in life, other than my family, ….

Helping and improving the life of my patients.

Neil Floch MD @NeilFlochMD Oct 29

There is a new goal for obesity and its associated disease… normal weight and disease remission.

The time of…. Just making it a little better is no longer good enough.

We have the tools and the medical and surgical trends of treatment are moving in the right direction for medications. Surgery remains necessary and most effective for higher bmi and many medical conditions.

Metabolic Surgery and gut hormone medications such as GLP-1/GIP work together in an additive effect. Let’s use all the tools to achieve

🎯 Target weight!!!

Philip Schauer, MD Verified account @PSchauerMD Oct 29

We should aim for disease remission, not just A1c improvement or % weight loss. So far, only metabolic surgery has shown diabetes remission beyond 10 years. Early intervention is key. Don’t wait until after exhausting every medication. @AmDiabetesAssn @ADA_DiabetesPro @TheAACE @TheEndoSociety @ObesitySociety @OMAsocial @ASMBS @IfsoSecretariat @JaimePonceMD @NeilFlochMD @FRubinoMD @francois_pattou @rvcohen @Ali_Aminian_MD @metabolic_knife @carel_leroux @IldikoLingvay @JaimeAlmandoz @DrJohnKirwan @PBRCNews @MBSDigest
View quoted post on X

Neil Floch MD @NeilFlochMD Oct 29

This is a brilliant strategy as patients need to have access to multiple options. Some patients will respond to one drug and not another. Patients will need to switch drugs if they stop losing weight or hunger returns. Others will be able to “add on” a drug like Amalyn - yet others may need metabolic surgery in the mix when overall response is simply not enough, especially starting at a bmi of 50.

On The Pen™ Verified account @ManOnThePen Oct 29

Lilly’s view of a consumer-driven obesity market is becoming very clear:

Build a portfolio, then let patients move through it.

Foundayo as an on-ramp or maintenance option. Tirzepatide as the cornerstone. Retatrutide for greater power. Amylins as another pathway entirely.

Lilly says the goal is to let patients “start, switch and step up” to whichever medicine works best for them.

Consumers will ultimately be choosing from an entire therapeutic ecosystem.

$LLY
View quoted post on X

Neil Floch MD @NeilFlochMD Oct 29

In this world, we are short of great leaders.
Great leaders in sports teach most effectively about life.
In real life we don’t always see the cause and effect of leadership- as we are not always privy to the facts. Facts are often exaggerated or dampened but sports don’t lie. We see real events unfolding live on television.
Leaders perform and are self-evident.
One such leader, is not always the most successful on the field but always the role model in the club house and locker room.

That is Jameis Winston @Jaboowins of the @Giants

Despite losing the starting job, he vigorously teaches the new starting quarterback, he motivates the players, and commands the team.

A lesson for leaders in every walk of life…

Neil Floch MD @NeilFlochMD Oct 29

Effective obesity treatment is mostly composed of diet change, exercise, gut hormone based therapy (GLP-1/GIP). It also includes metabolic bariatric surgery in a much smaller percentage. All are needed to effectively treat society.